Novartis, Emirates Cardiac Society extend support to heart failure patients through ‘Your Heart Can’t Wait’ campaign
Leading global medicines company Novartis collaborated with the Emirates Cardiac Society to support patients that suffer from heart failure as well as raise awareness among those that are at risk of the condition in the UAE
There is more: Novartis strengthens support for women living with breast cancer
Company partnered with the Friends of Cancer Patients and the Emirates Oncology Society to educate women about the importance of regular screenings in the early detection and treatment of breast cancer
26 October 2022; Dubai, United Arab Emirates — Novartis, one of the world’s leading pharmaceutical companies, is sending out a strong message of hope for women across the region that have been diagnosed with breast cancer.
Women in Pink campaign pledges to raise awareness onbreast cancer in the UAE Leading global medicines company Novartis tackles rise in breast cancer by encouraging women to take charge of their health.
Novartis and Pharmax collaborate to enhance access to quality medicines across UAE, in alignment with MOHAP’s strategy
Strategic partnership between both organizations to serve UAE’s healthcare vision and enhance patient access to medication in key therapeutic areas such as diabetes and hypertension
“Collaborations such as these will strengthen the UAE’s healthcare vision to bring high-quality medicines in the country – and accelerate our position as a regional hub for medical practices, therapies, treatments, and pharmaceutical industries,” said H.E. Dr Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing at the Ministry of Health and Prevention.
Novartis presents significant study results during renowned Best of ESMO Conference in Dubai
Participating healthcare professionals attended the exclusively organized event by theEmirates Oncology Society in collaboration with the European Society of Medical Oncology targeting the Middle East and Africa region to bring the content and copyright of the data presented during the ESMO conference in September.
As the diamond sponsor of the event, Novartis also presented prominent study results for Phase III MONALEESA-2 as part of their latest medical updates and industry developments.